Clinical Trial Update: TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial studying Paclitaxel + Ifosfamide + Cisplatin with Nimotuzumab and Triprilimab as neoadjuvant therapy for locally advanced penile cancer has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• IFOSFAMIDE (IFOSFAMIDE)
• Nimotuzumab (nimotuzumab)
• PACLITAXEL (PACLITAXEL)
• Triprilimab (JS001)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Penile Cancer | Phase 2 | Status: COMPLETED